AMYLYX PHARMACEUTICALS, INC. Share | Buy US Stock from India on Kuvera

Q: Can I buy AMYLYX PHARMACEUTICALS, INC. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell AMYLYX PHARMACEUTICALS, INC. stocks after a simple registration process. </div>

Q: How to buy AMYLYX PHARMACEUTICALS, INC. shares in India?

<div> To buy AMYLYX PHARMACEUTICALS, INC. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for AMYLYX PHARMACEUTICALS, INC. and you are done!</div> </div>

Q: What is the share price of AMYLYX PHARMACEUTICALS, INC.?

<div>The share price of AMYLYX PHARMACEUTICALS, INC. is USD 3.5 as on 30 Jan.</div>

Q: What is the Market Capitalization of AMYLYX PHARMACEUTICALS, INC.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of AMYLYX PHARMACEUTICALS, INC. is USD 299.92M as on 30 Jan.</div>

Q: What is the PE ratio of AMYLYX PHARMACEUTICALS, INC.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of AMYLYX PHARMACEUTICALS, INC. is N/A as on 30 Jan. </div>

Q: Is AMYLYX PHARMACEUTICALS, INC. a good stock to buy?

<div>Kuvera provides relevant fundamental details of AMYLYX PHARMACEUTICALS, INC. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does AMYLYX PHARMACEUTICALS, INC. operate?

<div> AMYLYX PHARMACEUTICALS, INC. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$3.5

+0.04

(30 Jan)

Loading Chart

Previous close

$3.50

Open

$3.50

Today’s high

$3.60

Today’s low

$3.42

52W low

$1.57

52W high

$19.949

-77.50%

EPS (TTM)

-3.82

Shares O/S

85.69M

Market cap

299.92M

Insights

AMLX is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.

In beta. Send feedback here.

Compare with other stock

About AMYLYX PHARMACEUTICALS, INC.

Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS).

AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia. .

FAQs

Can I buy AMYLYX PHARMACEUTICALS, INC. shares in India?

How to buy AMYLYX PHARMACEUTICALS, INC. shares in India?

What is the share price of AMYLYX PHARMACEUTICALS, INC.?

What is the Market Capitalization of AMYLYX PHARMACEUTICALS, INC.?

What is the PE ratio of AMYLYX PHARMACEUTICALS, INC.?

Is AMYLYX PHARMACEUTICALS, INC. a good stock to buy?

In which sector / industry does AMYLYX PHARMACEUTICALS, INC. operate?